Effectiveness of ozonotherapyin the complex treatment ofchronic cystitisin women

Abstract


We surveyed a group of patients with chronic cystitis. The aim was to study effectiveness
of ozonotherapy in the complex treatment of such patients in the microcirculation of the
bladder wall, and change the composition of the microflora of the lower urinary tract. The
study involved 65 patients aged from 20 to 86. Patients were divided into three groups: the
first group of patients (n=20) received complex conservative therapy, the patient of the second
group (n=30) received, along with basic therapy intravesical instillation of ozonized solution,
the third group of patients (n=15) was carried parenteral injection of ozonized saline. The use
of ozonotherapy in the treatment of chronic cystitis in women has a pronounced bactericidal
effect, causes an improvement of microcirculation in the bladder wall, leading to rapid
disappearance of dysuric disorders.

About the authors

K A Sizov

K A Sizov

References

  1. Зайцев А.В. Диагностика и лечение интерстициального цистита у женщин. Дисс. док. мед. Наук, 1999
  2. Пушкарь Д.Ю., Дьяков В.В., Мацаев А.Б., Раснер П.И. Использование препарата Дальфаз СР в комплексной терапии больных хроническим циститом // Фарматека №10, 2006, с. 47-49
  3. Гехт Б.М., Шагал Д.И. Трудности и перспективы изучения микроциркуляции в клинике // Актуальные вопросы нарушения гемодинамики и регуляции микроциркуляции в клинике и эксперименте. - М., 1984, с. 278-280.
  4. Гаджиева З. К. Уродинамические исследования в диагностике и лечении нарушений мочеиспускания // Дисс. докт. мед. наук. М., 2009, 319 с.
  5. Еселевский Ю.М., Хайрлиев Г.З. Способ определения скрытого нарушения кровообращения мочевого пузыря у женщин // Урол. и нефрол. №4, 1994. с. 14-17.

Statistics

Views

Abstract - 38

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions

Refbacks

  • There are currently no refbacks.

Copyright (c) 2012 Sizov K.A., Sizov K.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies